University Health Network:製薬・医療:M&Aディール及び事業提携情報

GlobalDataが発行した調査報告書(DATA904C5156)
◆英語タイトル:University Health Network - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C5156
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年9月
◆ページ数:37
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
University Health Network (UHN) is a health care institution that provides patient care, research and educational services, and patient support services. It offers health care services such as palliative care, pharmacy and telehealth. UHN also provides specialized program services, accessibility, health records, hospitality services and volunteer resources. The organization conducts research in the fields of neurosciences, cardiology, oncology, transplantation, surgical innovation, genomic medicine, infectious diseases, and rehabilitation medicine. UHN is a network of health care and teaching institutions, namely, Toronto General and Toronto Western Hospitals, the Princess Margaret Cancer Centre, Toronto Rehabilitation Institute and The Michener Institute of Education at UHN. It is a research hospital affiliated to the University of Toronto. UHN is headquartered in Toronto, Ontario, Canada.

University Health Network – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University Health Network, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University Health Network, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
University Health Network, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University Health Network, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
University Health Network, Medical Devices Deals, 2012 to YTD 2018 9
University Health Network, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
University Health Network, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Theralase Technologies Expands its Research Agreement with University Health Network 11
OncoTherics Enters into Agreement with University Health Network 12
Blueline Bioscience Forms Joint Venture with University of Toronto and University Health Network 13
Licensing Agreements 14
VistaGen Therapeutics Enters into Licensing Agreement with University Health Network 14
Avrobio Enters into Licensing Agreement with University Health Network 15
Avrobio Enters into Licensing Agreement with University Health Network 16
VistaGen Therapeutics Enters Licensing Agreement with University Health Network 17
Sernova Enters into Licensing Agreement with University Health Network 18
Trillium Therapeutics Amends Licensing Agreement with University Health Network 19
Stem Cell Therapeutics Enters Into Option For Licensing Agreement With University Of Toronto 20
University Health Network – Key Competitors 22
University Health Network – Key Employees 23
University Health Network – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Corporate Communications 25
Mar 12, 2018: Dr. Kevin Smith Appointed President & Chief Executive Officer of University Health Network 25
Government and Public Interest 26
Nov 23, 2017: Innovative Medicines Canada and Astellas Announce Grant to the University Health Network’s Transplant Innovation Fund 26
Nov 15, 2017: Molecular pathway offers treatment targets for pulmonary fibrosis, related conditions 27
Nov 06, 2017: UHN Vision Scientists Discover Potential Neuroprotective Treatment For Glaucoma 29
Oct 13, 2017: Neurotechnological innovation and organ-on-a-chip engineering centres receive more than $10 million in new funding 30
Mar 16, 2017: Prostate Cancer Clinical Trial Shows Treating With Precision Radiotherapy Reduces Course of Treatment by 50 Per Cent 31
Mar 07, 2017: Ovarian Cancer Researchers Identify Biomarker Linked to Prognosis in Aggressive Disease Type 32
Product News 33
Jul 09, 2018: Leukemia Researchers Discover Genetic Screening Tool to Predict Healthy People at Risk for Developing AML 33
Feb 06, 2017: Immune therapy scientists discover distinct cells that block cancer-fighting immune cells 35
Other Significant Developments 36
Apr 12, 2017: University Health Network: First-of-its-kind app offers personalized rehab therapy for stroke patients 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
University Health Network, Pharmaceuticals & Healthcare, Key Facts 2
University Health Network, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University Health Network, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
University Health Network, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University Health Network, Deals By Therapy Area, 2012 to YTD 2018 8
University Health Network, Medical Devices Deals, 2012 to YTD 2018 9
University Health Network, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Theralase Technologies Expands its Research Agreement with University Health Network 11
OncoTherics Enters into Agreement with University Health Network 12
Blueline Bioscience Forms Joint Venture with University of Toronto and University Health Network 13
VistaGen Therapeutics Enters into Licensing Agreement with University Health Network 14
Avrobio Enters into Licensing Agreement with University Health Network 15
Avrobio Enters into Licensing Agreement with University Health Network 16
VistaGen Therapeutics Enters Licensing Agreement with University Health Network 17
Sernova Enters into Licensing Agreement with University Health Network 18
Trillium Therapeutics Amends Licensing Agreement with University Health Network 19
Stem Cell Therapeutics Enters Into Option For Licensing Agreement With University Of Toronto 20
University Health Network, Key Competitors 22
University Health Network, Key Employees 23
University Health Network, Subsidiaries 24

List of Figures
University Health Network, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
University Health Network, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
University Health Network, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
University Health Network, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
University Health Network, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University Health Network, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
University Health Network, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University Health Network, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
University Health Network, Medical Devices Deals, 2012 to YTD 2018 9

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ University Health Network:製薬・医療:M&Aディール及び事業提携情報(University Health Network - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆